Effects of ubidecarenone in an exercise training program for patients with chronic obstructive pulmonary diseases

A. Satta, M. Grandi, C. V. Landoni, G. B. Migliori, A. Spanevello, G. Vocaturo, M. Neri

Research output: Contribution to journalArticlepeer-review

Abstract

A study was undertaken to determine the usefulness of ubidecarenone in pulmonary rehabilitation in exercise training programs in the management of chronic obstructive pulmonary disease (COPD). The subjects were 20 patients with COPD who had been participating in an exercise training program for at least four weeks. The patients were randomly assigned either to receive 50 mg of oral ubidecarenone daily or to enter a control group during the program. Oxygen consumption, expired volume, and heart rate were measured during exercise tests before and after training. Maximum oxygen consumption increased 13% in the ubidecarenone-treated patients and 7% in the controls, and maximum expired volume increased 10% in each group. The increases were significant in the ubidecarenone group but not in the controls. Heart rate increased 2% in both groups. It is concluded that ubidecarenone deserves further evaluation in exercise training programs for patients with COPD.

Original languageEnglish
Pages (from-to)754-757
Number of pages4
JournalClinical Therapeutics
Volume13
Issue number6
Publication statusPublished - 1991

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Effects of ubidecarenone in an exercise training program for patients with chronic obstructive pulmonary diseases'. Together they form a unique fingerprint.

Cite this